(PDF) Behavioural Pharmacology of the Α5-Gaba a Receptor

Behavioural Pharmacology of the Α5-Gaba a Receptor Antagonist S44819: Enhancement and Remediation of Cognitive Performance in Preclinical Models

Neuropharmacology - United Kingdom

doi 10.1016/j.neuropharm.2017.07.005

Full Text

Abstract

Available in full text

Categories

Molecular Neuroscience

Date

October 1, 2017

Authors

István Gacsályi

Krisztina Móricz

János Wellmann

József Barkóczy

Jeremy J. Lambert

Gábor Szénási

Michael Spedding

Ferenc A. Antoni

Publisher

Elsevier BV

Related search

Specific Targeting of the GABA-A Receptor Α5 Subtype by a Selective Inverse Agonist Restores Cognitive Deficits in Down Syndrome Mice

Journal of Psychopharmacology

English

Pharmacology of the GABA Receptor Functions in the Central Nervous Systems

Yakugaku Zasshi

Pharmaceutical Science

English

Neurobiology and Therapeutic Potential of Α5-Gaba Type a Receptors

Frontiers in Molecular Neuroscience

Molecular Neuroscience

Molecular Biology

English

Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials

English

Cognitive Resilience in Clinical and Preclinical Alzheimer’s Disease: The Association of Amyloid and Tau Burden on Cognitive Performance

Brain Imaging and Behavior

Molecular Neuroscience

Nuclear Medicine

Cognitive Neuroscience

Behavioral Neuroscience

English

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis

Clinical Pharmacokinetics

English

Behavioural Pharmacology. 2nd Ed

Journal of Neurology, Neurosurgery and Psychiatry

English

Interleukin-1 Receptor Antagonist in Animal Models of Stroke: A Fair Summing Up?

Journal of Stroke and Cerebrovascular Diseases

Cardiovascular Medicine

English

A Meta-Analysis of Cognitive Remediation in Schizophrenia

American Journal of Psychiatry

English